Medications

GLP-1 and Glucagon: How These Two Hormones Work Together (and Against Each Other)

If you've started looking into GLP-1 medications, you've probably heard a lot about what GLP-1 does—it helps control blood sugar, reduces appetite, and supports weight loss. But there's another hormone in your body that plays an equally important role in your metabolism, and it works in almost the complete opposite way: glucagon. Understanding how these two hormones interact can help you better understand what's happening in your body when you take GLP-1 medications.

What Is Glucagon?

Glucagon is a hormone produced by your pancreas, just like insulin. But while insulin helps lower blood sugar by moving glucose into your cells, glucagon does the opposite—it raises blood sugar when levels drop too low.

Think of glucagon as your body's emergency fuel system. When you haven't eaten in a while or your blood sugar dips, your pancreas releases glucagon. This hormone tells your liver to break down stored glycogen (stored sugar) and release it into your bloodstream. It's a survival mechanism that kept our ancestors going between meals.

Glucagon also plays a role in fat metabolism by promoting the breakdown of stored fat for energy. In healthy metabolism, glucagon and insulin work in a careful balance throughout the day.

How GLP-1 and Glucagon Work as Opposites

GLP-1 (glucagon-like peptide-1) and glucagon are often described as having opposite effects on your body, and for good reason.

After You Eat

When you eat a meal, your body releases GLP-1 from cells in your intestine. This hormone stimulates insulin release, which helps lower blood sugar. At the same time, GLP-1 actively suppresses glucagon secretion. This makes sense—you just ate, so you don't need glucagon telling your liver to release more sugar into your bloodstream.

In people with type 2 diabetes, this system doesn't work as well. Glucagon levels often remain inappropriately high even after eating, which contributes to elevated blood sugar levels. This is one reason why GLP-1 medications can be so effective.

Between Meals

When your stomach is empty and blood sugar starts to drop, the opposite happens. GLP-1 levels decrease, and glucagon secretion increases. This shift helps maintain stable blood sugar between meals by releasing stored glucose.

This back-and-forth creates a natural rhythm that keeps your energy steady throughout the day—at least, that's how it works when everything is functioning properly.

Why This Relationship Matters for Weight Loss

The interplay between GLP-1 and glucagon has significant implications for metabolism and weight management.

When you take GLP-1 medications like semaglutide or tirzepatide, you're essentially amplifying one side of this relationship. By increasing GLP-1 activity, these medications help suppress excess glucagon secretion, which is especially helpful for people whose bodies are producing too much glucagon at the wrong times.

This suppression helps in several ways:

By restoring a more balanced relationship between these hormones, GLP-1 medications help create the metabolic conditions that support weight loss.

The Dual-Hormone Approach: What Makes Tirzepatide Different

While medications like semaglutide work primarily as GLP-1 receptor agonists, tirzepatide takes a unique dual approach. It activates both GLP-1 receptors and GIP (glucose-dependent insulinotropic polypeptide) receptors.

GIP is another incretin hormone that, among other effects, influences glucagon secretion. Some research suggests that GIP may help modulate glucagon in ways that support fat metabolism while still maintaining healthy blood sugar control. This dual action may be one reason why some people experience robust results with tirzepatide.

The relationship is complex, and researchers are still working to fully understand how these multiple hormone pathways interact. What we do know is that addressing multiple parts of this hormone system can lead to meaningful improvements in metabolic health.

Gender Differences in Hormone Response

While both men and women produce GLP-1 and glucagon, there are some differences in how these hormones function across the sexes.

Women may experience different patterns of hormone secretion related to menstrual cycles, with some research suggesting variations in GLP-1 response at different cycle phases. Women also tend to have different body composition and fat distribution patterns than men, which can influence how glucagon affects fat metabolism.

Men typically have higher muscle mass, which affects insulin sensitivity and may influence the glucagon response during fasting or exercise. Some studies suggest men may experience slightly different hunger responses to GLP-1 medications, though individual variation is significant in both sexes.

The good news is that GLP-1 medications have been shown to work effectively across genders. Your individual response will depend more on your unique metabolism, health history, and lifestyle factors than simply on being male or female.

What This Means for Your Treatment

Understanding the GLP-1-glucagon relationship can help set realistic expectations for your treatment journey.

First, it explains why GLP-1 medications work best when combined with dietary changes. By eating in a way that supports stable blood sugar, you're working with these hormones rather than against them. Consistent meal timing and balanced nutrition help optimize the natural rhythm between GLP-1 and glucagon.

Second, it helps explain some of the side effects you might experience. As your body adjusts to having higher levels of GLP-1 activity and reduced glucagon response, you may notice changes in hunger patterns, energy levels, and digestion. These typically improve as your body adapts.

Finally, this hormone relationship underscores why GLP-1 therapy is about more than just appetite suppression. You're actually helping restore a more functional metabolic balance that may have been disrupted for years.

From the Ozari Care Team

We often see patients worried about low blood sugar when starting GLP-1 medications, but the glucose-dependent nature of how these medications work with glucagon makes severe hypoglycemia rare in people not taking insulin or sulfonylureas. Your body's natural glucagon response remains available when you truly need it. That said, always follow your prescribed eating schedule and reach out if you experience unusual symptoms.

At Ozari Health we offer compounded Semaglutide and Tirzepatide starting at $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 29, 2026